Press release
Angina Market Poised for 6.1 % Growth, Set to Hit $1.72 Billion by 2029
Angina Market Size
The growth of the angina market is anticipated to be driven by the increasing instances of coronary artery diseases. Known as coronary heart disease (CHD) or ischemic heart disease (IHD) as well, coronary artery disease (CAD) is a condition marked by the constriction or obstruction of the coronary arteries delivering blood, oxygen, and nutrients to the cardiac muscle. The rising incidence of CAD can be attributed to shifts in lifestyle and environmental and genetic factors. Angina has a crucial part in detecting and comprehending the prevalence of CAD. Its existence triggers medical assessment and diagnosis, aids in risk stratification, influences therapeutic choices, and steers public health tactics. As per the American Heart Association, the CAD-affected adult population in the U.S. increased from 18.2 million to an estimated 19.3 million between 2021 and 2022. Consequently, the escalating instances of coronary artery diseases are propelling the angina market.
Get Your Angina Market Report Here:
https://www.thebusinessresearchcompany.com/report/angina-global-market-report
What is the projected compound annual growth rate (CAGR) of the angina market from 2025 to 2034, and what factors influence it?
The market size for angina has experienced robust growth in the past few years. The projected increase is from $10.71 billion in 2024 to $11.4 billion in 2025, with a compound annual growth rate (CAGR) of 6.4%. Factors contributing to this growth during the historic period include a higher frequency of coronary heart disease, greater utilization of vasodilators, an increased incidence of myocardial ischemia, advancements in diagnostic abilities, and a rise in the application of imaging techniques.
Over the coming years, the angina market size is projected to experience robust growth, increasing to $14.44 billion by 2029 with a compound annual growth rate (CAGR) of 6.1%. Factors propelling the growth during the forecast period include the rising incidence of chronic angina pectoris, increased drug approvals and clinical studies, growing demand in retail pharmacies, heightened awareness of cardiovascular health, and an escalating demand for medications. Foreseen trends within the forecast period encompass advancements in early diagnosis technology, developments in angioplasty and stenting procedures, innovative gene therapy methodologies, increased demand for coronary stents, and progress in treatments for coronary artery disease.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16337&type=smp
How are the latest trends influencing the growth of the angina market?
Leading firms in the angina market are focusing on the creation of revolutionary drugs such as metoprolol tartrate tablets, a novel approach in providing more efficacious and patient-centered treatments for coronary artery disease (CAD) and other related conditions. Metoprolol tartrate tablets, widely known as effective treatment for different cardiovascular issues like angina, hypertension and heart failure, are of growing appeal. For instance, in April 2023, Zydus, a renowned pharmaceutical company based in India, secured the final nod from the United States Food and Drug Administration (US-FDA) to produce and sell its generic equivalent of Metoprolol Tartrate Tablets USP in dosages of 25 mg, 50 mg, and 100 mg. Metoprolol, a beta blocker, is typically used to address various cardiovascular ailments, including hypertension and angina, and to enhance survival rates post a cardiac arrest.
What are the major segments of the angina market and their role in driving growth?
The angina market covered in this report is segmented -
1) By Type: Angina Pectoris, Unstable Angina, Prinzmetal Angina, Other Types
2) By Treatment: Lifestyle Changes, Medications, Angioplasty And Stenting, Coronary Bypass Surgery, Other Treatments
3) By Drug Class: Beta Blockers, Nitrates And Calcium Channel Blockers, Angiotensin-Converting Enzyme Inhibitors, Other Drug Classes
4) By Application: Clinics, Hospitals, Other Applications
Subsegments:
1) By Angina Pectoris: Stable Angina, Chronic Stable Angina, Effort-Induced Angina, Variant Or Microvascular Angina
2) By Unstable Angina: Acute Unstable Angina, Pre-Infarction Angina, Rest Angina
3) By Prinzmetal Angina: Vasospastic Angina, Coronary Artery Spasm-Induced Angina, Variant Angina
4) By Other Types: Nocturnal Angina, Post-Infarction Angina, Angina With Silent Myocardial Ischemia, Angina Due To Aortic Stenosis Or Valve Disease
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16337
Which regions are key players in the growth of the angina market?
North America was the largest region in the angina market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angina market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the key firms paving the way for growth in the angina market?
Major companies operating in the angina market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co Inc., Bayer AG, Sanofi S.A., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott laboratories, GlaxoSmithKline Plc, Eli Lilly and Company, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Troikaa Pharmaceuticals Ltd, Amgen Inc., Dr. Reddy's Laboratories, ViroMed Co. Ltd., Lee's Pharmaceutical Holdings, Kuhnil Pharmaceutical, LegoChem Biosciences, Axus Cardium Pharmaceuticals, Juventas Therapeutics, Milestone Pharmaceuticals
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=16337&type=smp
What Is Covered In The Angina Global Market Report?
•Market Size Forecast: Examine the angina market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the angina market for a structured understanding.
•Key Players Overview: Analyze major players in the angina market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the angina market.
•Segment Contributions: Evaluate how different segments drive overall growth in the angina market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the angina market.
•Industry Challenges: Identify potential risks and obstacles affecting the angina market.
•Competitive Landscape: Review strategic developments in the angina market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Angina Market Poised for 6.1 % Growth, Set to Hit $1.72 Billion by 2029 here
News-ID: 3920119 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Angina
Angina Market Key Players, Trends & Forecast to 2034
The Angina Market is experiencing steady growth worldwide as heart disease cases rise and healthcare providers adopt advanced diagnostic tools, novel anti-anginal medications, and cutting-edge interventional cardiology treatments. With precision diagnostics, long-acting drug therapies, and improved cardiac revascularization techniques, the market is set for substantial expansion through 2034.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/52004
1. What Is Angina? (Keyword Definition)
Angina pectoris-commonly known as angina-is chest pain or discomfort caused…
Surging Prevalence Of Cardiovascular Diseases Propels Growth In The Angina Pecto …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Angina Pectoris Drugs Market Size By 2025?
The market size for angina pectoris drugs has experienced consistent growth in the past few years. The market is projected to expand from $12.32 billion in 2024 to $12.88 billion in 2025, representing a compound annual growth rate…
Angina (Angina Pectoris) Pipeline: 10+ Companies Transforming Chest Pain Managem …
The angina therapeutics pipeline is experiencing a renaissance, driven by pharmaceutical companies such as Abbott Laboratories, AstraZeneca, Bayer AG, and Bristol-Myers Squibb. With a focus on improving myocardial efficiency and reducing ischemic burden, emerging therapies-including metabolic modulators, nitric oxide donors, and gene therapies-aim to offer more effective symptom relief and reduce cardiovascular events. Innovations are targeting both stable and microvascular angina forms, addressing the significant unmet needs in chronic angina…
What's Driving the Angina Market 2025-2034: The Rising Prevalence of Coronary Ar …
What Are the Projections for the Size and Growth Rate of the Angina Market?
The scale of the angina market has seen robust growth in the previous years. The expansion is expected to continue, increasing from a value of $10.71 billion in 2024 to $11.4 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.4%. The surge in the past period can be credited to factors such as a…
Angina Pectoris - Drug Pipeline Landscape, 2022
Global Angina Pectoris Market report from Global Insight Services is the single authoritative source of intelligence on angina pectoris market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types,…
Angina Pectoris - Drug Pipeline Landscape, 2022
Angina also known as angina pectoris, is a type of chest pain or discomfort that occurs when a part of the heart doesn't get enough blood and oxygen, which is due to the spasm or obstruction of the arteries that supply the blood to the heart muscles. Angina is mainly of four types: stable angina, unstable angina, microvascular angina, and vasospastic or variant angina.
Angina is caused due to the built…
